据华尔街日报2月5日报道,英国牛津大学和阿斯利康联合开发的新冠疫苗对英国发现的变异毒株的有效率为75%。华尔街日报强调,以上发现来自小规模研究,且是初步的结果,还没有得到其他科学家的正式审查。
另外,据路透社2月5日消息,牛津疫苗试验的首席研究员安德鲁·波拉德表示,在英国进行的ChAdOx1疫苗试验的数据表明,阿斯利康/牛津新冠疫苗不仅可以抵御最初的病毒,还可以抵御新变体B.1.1.7。
老虎资讯综合2021-02-05
据华尔街日报2月5日报道,英国牛津大学和阿斯利康联合开发的新冠疫苗对英国发现的变异毒株的有效率为75%。华尔街日报强调,以上发现来自小规模研究,且是初步的结果,还没有得到其他科学家的正式审查。
另外,据路透社2月5日消息,牛津疫苗试验的首席研究员安德鲁·波拉德表示,在英国进行的ChAdOx1疫苗试验的数据表明,阿斯利康/牛津新冠疫苗不仅可以抵御最初的病毒,还可以抵御新变体B.1.1.7。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial